suggest that PL, a 22-kD polypeptide hormone produced by the fetal placenta, plays a role in the control of fetal growth. PL circulates in fetal plasma from midgestation to parturition in hum ans, sheep, cows, and mice (for review see Ref. 4) and binds with high affinity to microsomal fractions of ovine (5-9) and human fetal liver (10), bovine endometrium (11, 12) , and human fetal skeletal muscle (10). PL exerts metabolic effects on glycogen metabolism in isolated fetal sheep and rat hepato cytes (6, 13-15) and stimulates amin o acid uptake , [3H]thymidin e incorporation , and IGF production in hum an fetal fibroblasts, myoblasts, and pancre atic islet cells (16) (17) (18) . In the mid-and lategestation human fetus, plasma PL concentrations correlate positively with fetal plasma IGF-I concentrations and independently with birth weight (19).
GH, growth hormone PL, placental lactogen PRL, prolactin oPL, ovine placental lactogen oGH, ovine growth hormone oPRL, ovine prolactin BS 3 , Bis(sulfosuccinimidyl)suberate EC so, 50% effective concentration ABSTRACT. Growth hormone (GH) regulates growth and development in the postnatal period but lacks somatotropic activity in the fetus. In contrast, the placental hormone placental lactogen (PL) stimulates amino acid transport, DNA synthesis, and somatomedin production in isolated fetal tissues, suggesting that PL may function as a "fetal GH ." To elucidate the mechanisms by which PL exerts GH-like effects in fetal tissues, we examined the binding of PL, GH, and prolactin to cultured skin fibroblasts obtained from midgestational fetal lambs. Ovine fetal fibroblasts bound radiolabeled ovine PL (oPL) specifically and with high affinity (EC so 0.20 nM). In competitive displacement assays using 12sI_oPL as the radioligand, the potency of unlabeled oPL was eight to 12 times greater than that of ovine GH and ""'1000 times greater than that of ovine prolactin. Covalent cross-linking of 12sI_oPL (22 kD) to ovine fetal fibroblasts revealed a specific hormonereceptor complex with an apparent M, of 130 000, suggesting that the high affinity oPL binding site has a molecular mass of approximately 108 kD. The specific bindings of radiolabeled ovine GH (0.6 % per 250 ILg protein) and ovine prolactin (0.04% per 250 ILg protein) were only 1/15 and 11230 that of radiolabeled oPL (9.1 % per 250 ILg protein), and no specific cross-linking of 125I-ovine GH or 125I-ovine prolactin to ovine fetal fibroblasts was detected. These findings demonstrate preferential binding of PL by isolated fetal sheep fibroblasts in culture, providing a cellular mechanism whereby PL may exert growth-promoting effects in the fetus. (Pediatr Res 32: 200-203, 1992) The human fetus at midgestation grows at a rate 12 time s greater than that of the child in midpuberty (1); however, the regulation of fetal growth by fetal and placental hormones is poorl y understood (2) . Although GH plays a major role in the control of postnatal growth, it appears to play little or no role in the control of growth in the fetus (2, 3) . Several lines of evidence   PL BINDING TO FETAL FIBROBLASTS   20l   10000  10 100 1000
Hormone (ng/ml) Fig. 4 . Effects of unlabeled oPL, oGH, and oPRL on the binding of 125I_oPL to fetal sheep fibroblasts. Radiolabeled oPL ("" 100 000 cpm/ well)was incubated with fetal sheep fibroblasts in the absence or presence of increasing concent rations of either oPL, oGH, or oPRL at 4°C for 20 to 24 h. Percentage of specific binding was calculated by subtract ing the amount of binding that occurred in the presence of unlabeled hormone from the total binding and expressed as a percentage of the total radioactivity added. Values represent the mean ± SEM of triplicate values. Curve fitting was generated by a one-site competitive binding curve equation using INPLOT software. Similar or identical results were noted in five separate experiments. Cross-linking of 125I-oPLand 125I_oGH tofetal skin fibroblasts in culture. Confluent monolayers of fetal fibroblasts plated in 35- mnr' wells were washed three times with 2 mL cold binding buffer and then incubated for 20 to 24 h at 4°C with bi nding buffer containing I 25I_oPL , '25I_oGH, or 125I_oP RL (""'1 X 10 6 cprn/well) in the absence or presence of u nl abeled oPL (200 ng / mL), oGH (3 }-tg/ m L), or oPRL (3 }-tg/ mL). At the end of the incubatio n, cells were was hed three times with 2 mL co ld binding buffer without BSA and were then incu bated for 20 m in at 4°C in I mL of 25 mM N-2-hydroxyethylpip erazin e-N' -2-ethan esu lfonic ac id, 10 mM M gCh (pH 7.5) , containing 0.5 mM DS S or 0 .5 mM BS 3 at 4OC. The cells were then washe d extensively in co ld binding buffer without BSA and sol ubilized in 50 }-tL of electrophoresis sample buffer uoo mM Tris, pH 6.8, 4 % SDS , Fig. 5 . Cross-linking of 125I_oPL and 1251_oGH to fetal sheep fibroblasts. Fetal sheep fibroblasts were incubated with 125I_oPL or 125I_oGH ("" I X 10 6 cpmjmL) in the presence (+) or absence (-) of oPL, oGH, or oPRL at 4°C for 20 to 24 h. Cross-linking was performed using 0.5 mM DSS as described in Materials and Methods. Solubilized cell extracts were analyzed on a 7.5% SDS-polyacrylamide gel under reducing conditions. Free radioactivity at the bottom of the gel was cut off. Similar or identical results were noted in at least four separate experiments.
MW
J8 0 K- 2 .5 mM M gCh , 11 mM glucose, 0. 1% BSA, pH 7.5) . Ce lls were incubated with either radiolabeled oPL, recom bin ant oPL, oGH, or oPRL (each ""'100 000 cpm, "'" 0.1 nM) in the pres ence or absence of u nlabeled hormon es for various times and tem p eratures to determine rece ptor saturability, affinity, and ti me and temperature dependen ce. Bind ing was terminated by washing the cells three times with cold binding buffer; the cells were then 
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FOWLKES AND FRE EMARK 0.2% bromphenol blue, 20% glycerol, 5% iJ-mercaptoethanol) (22) overnight at 3rC in a humidified chamber on a rocking platform. The individu al samples were then boiled for 3 min and anal yzed on 7.5% SDS-polyacrylamide gels (Bio-Rad Laboratories, Richmond, CA) at 12 rnA/gel. The gels were dried using a vacuum drying apparatu s (Bio-Rad) and subjected to autoradiography using Kodak X-OMAT film and intensifying screens for 4 to 7 d at -70°C. The molecular weights of the radioactive hormone-receptor complexes were estimated by comparison with prestained molecular weight stand ards (Sigma Chemical Co., St. Lou is, MO).
Data analysis. The binding of 12sI_oPL to fetal sheep skin fibroblasts was examined in the presence or absence of varying concentrations (0.1 ng to 5 JLg/mL) of unlab eled oPL, oGR, and oPRL. The total bind ing of 12sI_oPL was expressed as the percentage of radiolabeled hormone bound to cell monolayers. Specific binding was calculated by subtracting the amount of binding that occurred in the presence of excess (10 JLg/mL) unlabeled hormone (nonspecific binding) from the total binding. The relative poten cies of oPL, oGR, and oPRL in comp eting for binding to these sites were estimated by analysis of competitive binding data using LIGAND (23) and INPLOT (GraphPAD Software, San Diego, CA) software. In all experiments, the binding of 125I_oPL, 125I_oGR, 125I_oPRL to fetal sheep fibroblasts was determined in either duplicate or triplicate samples and was expressed relative to the protein content of each sample (24) .
RESULTS

Time and temperature dependence of
125 I-oPL binding to fe tal sheep fibroblasts. Th e binding of 125I_oPL to fetal sheep fibroblasts was time and temperature dependent ( Fig. 1) . At 37OC, radio labeled oPL binding was rapid, reaching maximum levels in 30 min to I h and then declining precipitously to baseline by 2 h of incubation. The highest specific binding of 125I_oPL was observed during a 24-h incubation at 4°C. Under these conditions, there was no apparent degradation of ligand as assessed by rebinding of the tracer to fetal sheep fibroblasts or by trichloracetic acid precipitability. All subsequent experiments were performed at 20-24 h at 4°C.
Saturati on of oPL binding site in fetal sheep fibr oblasts. oPL binding to fetal sheep fibroblasts was saturable du ring a 24-h incubation at 4°C (Fig. 2) .
Comparative binding of oPL, oGH, and oPRL to fetal sheep fib roblasts. To examine the relative potencies of oPL, oGR, and oPRL in competing for the oPL bindin g site, fetal sheep fibroblasts were incubated with 125I_oPL (::::100000 cpm /well) in the presence or absence of increasing amounts of unlabeled oPL, oGR, or oPRL (Fig. 3) . Unlabeled oPL inhibited the binding of 125I_oPL in a dose-dependent fashion, with half-maxim al inhibition achieved at a concentration of 0.20 nM oPL. Althou gh oGR also was able to displace 125I_oPL from fibroblast binding sites, th e potency of oGR (EC 50 1.6-2.4 nM) was only one eighth to one twelfth that of oPL. Similarly, oPRL inhibited '25I_oPL binding only at high concentrations (EC50 > 200 nM). In addition, the specific binding of 125I_oGR (0.6% per 250 JLg protein) and 125I_oPRL (0.04% per 250 JLg protein) to fetal sheep fibroblasts was only 1 /15 and 11230 that of 125I_oPL (9.1% per 250 JLg protein) (Fig. 4) . These findings indicate that fetal sheep fibroblasts bind oPL with high affinity and oGR and oPRL with lower affinities.
Cross-linking of 125 I-oPL and 125I-oGH fetal sheep fibroblasts. T o characterize further the oPL and oGR binding sites on fetal sheep fibroblasts, cells were incubated with either 125I_oPL or 125I_oGR (each ::::1 x 10 6 cpm, ::::1.0 nM) for 20 to 24 h at 4°C. Nonspecific wells contained an excess of either unlab eled oPL, oGR, or oPRL (Fig. 5) . After washing the cells to remo ve unbound radioligand, radiolabeled horm ones were cross-linked to cellular binding sites using either the membrane-permeable cross-linking reagent DSS or the membrane-impermeable crosslinking reagent BS 3 . Cross-linking of 125I_oPL (22 kD) to its binding site produ ced specific radiolabeled complexes of 130, 85, and 60 kD (lane 1). Th e 130-kD comple x was abolished entirely in the presence of 200 ng/ml, unlabeled oPL (lane 2) or 3 JLg/mL oGR (lane 3), whereas oPRL was without effect (lane 4). Th is finding suggests that the M, of the high affinity oPL binding site in fetal fibroblasts is approximately 108000. The intensities of the 85-and 60-kD comple xes were reduced ::::50-80% by excess unlabeled oPL or oGR, but not oPRL. Studies using DSS or BS 3 produ ced similar cross-linked complexes, suggesting that the cross-linked prot eins are associated with the plasma membrane. Cross-linking of 125I_oPL to fetal fibroblasts produced one additional complex noted at the top of the gel (::::: 180 kD). This band may represent a large hormone-receptor compl ex, aggregated radioligand, and /or aggregated hormonereceptor comple xes. No specific cross-linking of 125I_oGR (lanes 5 and 6) or 125I_oPRL to fetal sheep fibroblasts was detected.
DISCUSSION
Although numerous studies have demonstrated that PL exerts direct metabolic and growth-promoting effects in fetal and maternal tissues durin g pregnan cy (4, 6, (13) (14) (15) (16) (17) (18) (25) (26) (27) , the init ial events in PL action at the cellular level are unknown. The stud ies described in this report are the first to characterize the binding of PL to isolated cells in culture, providing new insight into the mechanism s by which the horm one may regulate fetal growth. oPL bound to fetal sheep fibroblasts specifically and with high affinity (EC so 0.20 nM). The binding of oPL was tim e and temperature dependent; at 3rC, binding peaked rapidly and then declined, which suggests ligand internalization and/or degradation. Prelimin ary studies from our laboratory have demonstrated that the oPL receptor in fetal sheep fibroblasts is internalized rapidly after bindin g oPL at the cell surface; subsequently, the receptor-ligand complex may be recycled back to the cell surface or degraded (28) . The highest specific bindin g of oPL was noted at 4°C, a temperature at which ligand-r eceptor processing is minimized (29) .
The concentrations of oPL required for half-maximal binding to fetal sheep fibroblasts (0.20 nM) were comp arable to the concentrations of oPL in fetal sheep serum (25-100 ng/ml., 1.1-4.4 nM) (8, 30, 31) ; therefore, fibroblast binding sites in the sheep fetus would likely be occupied by oPL und er physiologic conditions. Two observations suggest that these sites bind oPL in preference to oGR and oPRL: first, the specific binding of radiolabeled oPL was 15 and 230 times greater than that of radiolabeled oGR and oPRL, respectively; and second, unlabeled oPL was eight to 12 times more potent than unlab eled oGR and :::: 1000 times more potent than unlabeled oPRL in competing for '25I_oPL bind ing. The preferential binding of PL to fetal cells in culture may explain in part the differences in potencies of PL, GR, and PRL in various assays of growth-promoting activity in fetal tissues (6, (25) (26) (27) .
The identity of the oPL binding site in fetal fibroblasts is unclear. Cross-linking of 125I_oPL to intact fetal sheep fibroblasts yielded hormone-receptor complexes of apparent M, of 130 000, 85 000, and 60 000. The 130-kD radio labeled complex was abolished by excess unlabeled oPL, which suggests that the high affinity oPL receptor in fetal fibroblasts has an M, of::::108 000. The intensities of the 85-and 60-kD comple xes were reduced markedly, but not abolished, by excess unlab eled oPL or oGR, which suggests the presence of lower affinity or non specific hormone binding sites. The M, of the high affinity oPL binding site in fetal sheep fibroblasts (108 000) differs from the apparent M, of the high affinity oPL receptor in fetal sheep liver membran es and soluble liver extracts (44 000 ± 2 000) (32) (33) (34) . Th e differences in apparent M, of the oPL binding sites in fetal sheep liver and fetal sheep fibroblasts might be explained in several ways: first, oPL receptors in various fetal sheep tissues may be heterogeneous in structure, with 44-and 108-kD variants; second, the oPL receptor in fetal sheep liver may be cleaved by proteolysis during the preparation of liver microsomes and detergent extracts, yielding a truncated 44-kD protein that conta ins the high affinity oPL binding domain; or third, the 108-kD oPL receptor in fetal sheep fibroblasts may represent a complex composed of a binding subunit (44 kD) and a closely associated integral membrane protein (60-64 kD). In this formulation, oPL (22 kD) may cross-link to the binding domain, forming a 60-65-kD complex, or to the complete membrane receptor, forming a 130-kD complex. Nonspecific binding to the associated membrane protein or subunit may produce the 85-kD complex noted in cross-linking studies.
Because the M, of the oPL binding site in fetal fibroblasts is similar to the M, of the GH receptor in various mammalian tissues (32, 35) , the fibroblast oPL receptor may be a variant of the oGH receptor. Alternatively, the oGH receptor in fetal skin fibroblasts may bind oPL with higher affinity than it binds oGH . The preferential binding of oPL by isolated fetal sheep fibroblasts pro vides a cellular mechanism by which PL may exert growthpromoting effects in the ovine fetus.
